presentazione di powerpoint · today tomorrow the neuromodulation market revenue data from...
TRANSCRIPT
![Page 1: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/1.jpg)
![Page 2: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/2.jpg)
Wiringless Implantable Stretchable Electronics
![Page 3: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/3.jpg)
WISE vison
Fast market entry with Cortical Grids.
Market Breakthrough with Foldable SCS paddles.
We will revolutionize
leads manufacturing
First to produce Neuro-leads: highly conformable, completely stretchable, minimally invasive.
![Page 4: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/4.jpg)
The Neuro-leads Scenario
Neuromodulation therapies:
Chronic pain (SCS)
Parkinson’s disease
Dystonia
Epilepsy
Depression
and many others …
Neuromonitoring Electrodes(iEEG)
NeurostimulationLeads (SCS, DBS)
Acute application:
Intra-Operative Neuro-Monitoring (IONM)
Identification of epileptogenic zones
![Page 5: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/5.jpg)
Today Tomorrow
The Neuromodulation Market
Revenue data from Corporate Annual Reports (2005-2016)
• Neuromodulation Rev. (2016): $3.4B
• 15% of Revenues come from Leads
Constant growth by
~10%
The limits of current leads technology
are major roadblock on the way to
new therapies.
![Page 6: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/6.jpg)
Current Market Problems
!
Neuromodulation LeadsNeuromonitoring Electrodes
INVASIVE
MIGRATION
BREAKAGE
LIMITED COMPLEXITY
HIGH PROD. COSTS
Bulky
Poorly conformable
Poorly stretchable
Low resolution
Hand assembled
![Page 7: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/7.jpg)
Arbitrarily thin
Highly conformable
Highly stretchable
High resolution
Automation
LOW INVASIVITY
NO MIGRATION
NO BREAKAGE
UNLIMITED COMPLEXITY
LOWER PROD. COSTS
Neuromonitoring Electrodes Neuromodulation Leads
The WISE Solution: Next-generation leads
![Page 8: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/8.jpg)
Neuro2World Connection
Soft tissue Hard electronic devices
Mechanical
mismatch
Hard metal leads
Conductiveelastomer
Device
Young’s Modulus (Pa)
![Page 9: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/9.jpg)
The WISE technology
Stretchable
polymer
Supersonic
cluster beam
source
Conductive
nanoparticles (Pt, Ir)
Unrivaled stretchability
Arbitrarily soft & thin substrate
Biocompatible (ISO 10993-1:2009 Tests)
Easy manufacturing Conductive stretchable
nanocomposite
PCT/EP2011/054903
![Page 10: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/10.jpg)
Easy Manufacturing
Arbitrarily soft & thin substrate (cold technology)
![Page 11: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/11.jpg)
No Engineering Limitations
Any shape
Any size (from m to cm)
200 m4 mm
Any polymer
Polyurethanes
PMMAsSilicones
![Page 12: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/12.jpg)
Robust Interconnection to standard electronics
wire
Robust interconnection
High risk of breakage
Need for wiring
Patent: PCT Nr. PCT/IB2017/053056
![Page 13: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/13.jpg)
Cortical Grids: Overview
Intra-operative or Acute: max 29 days
Monitoring/mapping the cortical surface during brain surgery (IOM) or before the surgical treatment of Epilepsy (ECoG)
Single-use
Cortical grids are used for the recording, monitoring and stimulation of electrical signal on the surface level of the brain.
![Page 14: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/14.jpg)
WISE’s Cortical Grids
![Page 15: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/15.jpg)
Cortical Grids: WISE vs. Commercial
COMMERCIAL
![Page 16: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/16.jpg)
Neuromodulation Leads: SCS Paddles
The first “Foldable SCS Paddle lead”
An SCS lead with all the advantages of a
Paddle lead
implanted byminimally invasive surgery
as a Percutaneous lead
![Page 17: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/17.jpg)
SCS leads: Paddle vs. Percutaneous
PercutaneousPaddles
Two types of Leads are used for SCS:
Better stim. (directional)
Invasive/Costly insertion
Precise stim. spot (grid)
Complex removal
Worse stim. (non directional)
Easy/Cheap insertion
Less Precise stim. spot
Easier removal
Surgically placed Implanted through a needle
WISE’s Foldable SCS Paddle lead
This will change the
SCS paradigm
Requires WISE’s technology
WISE’s Foldable SCS Paddle lead
![Page 18: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/18.jpg)
WISE’s Foldable SCS Paddle lead
Foldable in less than 4 mm
Product in development
![Page 19: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/19.jpg)
Patenting & kickoff
WISE’s Roadmap
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Angel round
Agite!2011
![Page 20: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/20.jpg)
Technology Consolidation
Patenting & kickoff
WISE’s Roadmap
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Angel round
Seed round
2012
250,000€ Investment
![Page 21: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/21.jpg)
Prototyping & Animal testing
Technology Consolidation
Patenting & kickoff
WISE’s Roadmap
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Angel round
Seed round
Seed+ round
€1M
2013
![Page 22: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/22.jpg)
Prototyping & Animal testing
Technology Consolidation
Patenting & kickoff
WISE’s Roadmap
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Angel round
Seed round
VC series A
€3M
Seed+ round
€1M
2015
CE mark / Market
Cortical Grids
Engineering,
Regulatory &
Clinical Trials
![Page 23: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/23.jpg)
Prototyping & Animal testing
Technology Consolidation
Patenting & kickoff
Foldable Paddle
Engineering,
Preclinical &
Clinical Trials
CE mark / Market
WISE’s Roadmap
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Angel round
Seed round
VC series B
€6.5M
VC series A
€3M
Seed+ round
€1M
CE mark / Market
Cortical Grids
Engineering,
Regulatory &
Clinical Trials
Tot. €11M
![Page 24: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/24.jpg)
WISE Factory
• 1000 m2 facility• Offices, Labs and Production• 120 m2 of ISO 7 cleanrooms
Production
R&D
Offices
120 m2 ISO7 Cleanroom
R&D Lab
Production Lab
Offices
![Page 25: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues](https://reader035.vdocuments.us/reader035/viewer/2022071416/61140a51881f2c4e780c8ec5/html5/thumbnails/25.jpg)
WISE’s Team